BioLargo, Inc. (OTCQX:BLGO) announced that its stockholders have approved a proposal allowing the board to implement a reverse stock split of up to 10-for-1. However, the company has no immediate plans to proceed with the split. The board intends to consider this option only if needed to meet the minimum price requirement for uplisting to a national exchange like Nasdaq or the New York Stock Exchange. BioLargo's CEO, Dennis Calvert, mentioned that the company is focused on its commercial strategy and expects an increase in stock price, with the reverse split serving as a strategic option if market conditions are favorable.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.